(Q34387677)

1 August 2017

1 reference

title

Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease (English)

1 reference

1 August 2017

0 references

cardiovascular disease

1 reference

1 reference

Palatini P

1

1 reference

1 August 2017

1 September 2001

1 reference

Current Hypertension Reports

1 August 2017

1 reference

1 August 2017

3 Suppl 1

1 reference

1 August 2017

S3-9

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-001-0065-z

1 August 2017

0 references

cites work

Overweight and hypertension : a 2-way street?

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0065-Z

Studies of the mechanisms underlying impairment of beta-adrenoceptor-mediated effects in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0065-Z

Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0065-Z

Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0065-Z

Reflex sympathetic activation induces acute insulin resistance in the human forearm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0065-Z

Parental hyperdynamic circulation predicts insulin resistance in offspring: The Tecumseh Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0065-Z

Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0065-Z

Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0065-Z

Renin release and the sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0065-Z

Pharmacology of eprosartan, an angiotensin II receptor antagonist: exploring hypotheses from clinical data

21 January 2018

1 reference

12 December 2020

Changes of cardiac output in hypertensive disease

1 reference

12 December 2020

Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist

1 reference

12 December 2020

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

12 December 2020

Association of tachycardia with morbidity and mortality: pathophysiological considerations

1 reference

12 December 2020

Plasma Volume in Men with Essential Hypertension

1 reference

12 December 2020

Cardiovascular effects of verapamil in essential hypertension

1 reference

12 December 2020

Impaired glucose tolerance, insulin resistance and cardiovascular disease

1 reference

12 December 2020

Participation of angiotensin II in pressor response and norepinephrine release to spinal nerve stimulation in pithed rats

1 reference

12 December 2020

Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance

1 reference

12 December 2020

Evidence for a specific heart disease of diabetes in humans

1 reference

12 December 2020

Determinants of left ventricular structure and mass in young subjects with sympathetic over-activity. The Tecumseh Offspring Study

1 reference

12 December 2020

The clinical implications of impaired glucose tolerance

1 reference

12 December 2020

An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension

1 reference

12 December 2020

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

1 reference

12 December 2020

Obesity, metabolism, and the sympathetic nervous system

1 reference

12 December 2020

Effects of oral salt loading on beta-adrenergic receptor responsiveness in normal and hypertensive subjects

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

12 December 2020

Detection and management of lipid disorders in diabetes. American Diabetes Association

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Influence of heart rate on mortality among persons with hypertension: the Framingham Study

1 reference

12 December 2020

Hypertension drug trials: past, present, and future

1 reference

12 December 2020

Heart rate and the cardiovascular risk

1 reference

12 December 2020

Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics.

1 reference

12 December 2020

Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan.

1 reference

12 December 2020

Supplement 1. American Diabetes Association: clinical practice recommendations 2000

1 reference

12 December 2020

The relation of adiposity to blood pressure and development of hypertension. The Framingham study

1 reference

12 December 2020

Disease entities, mixed multi-normal distributions, and the role of the hyperkinetic state in the pathogenesis of hypertension

1 reference

12 December 2020

Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine

1 reference

12 December 2020

Hematocrit and risk of coronary heart disease: the Puerto Rico Health Program

1 reference

12 December 2020

Epinephrine-induced insulin resistance in man.

1 reference

12 December 2020

Centrally acting antihypertensives: a renaissance of interest. Mechanisms and haemodynamics

1 reference

12 December 2020

Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension

1 reference

12 December 2020

Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man.

1 reference

12 December 2020

10.1007/S11906-001-0065-Z

Identifiers

DOI

1 reference

PubMed ID

11580882

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

11580882